As expected, IL-6 (100 ng/mL) stimulated a marked increase in p-STAT3 levels in all TCC cell lines, whereas sertindole co-treatment abrogated IL-6-upregulated p-STAT3 (Figure 3B). The gene discussed is STAT3; the disease is tarsal-carpal coalition syndrome.